GDUFA IV: US FDA Wants to ‘Streamline’ Formal Meeting Structure

The FDA wants to make the generic drug formal meeting system more efficient. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from United States